Diosmin Tablets

This product is a drug that enhances venous tone and a vascular protective agent. 1. Pharmacology The drug exerts its active effects on the venous vascular system in the following ways: 1.1 Reduces venous distensibility and venous blood stasis. 1.2 In the microcirculatory system, it normalizes the permeability of the capillary wall and enhances its resistance. 2. Clinical Pharmacology In humans, a double-blind controlled study method was used to verify and quantitatively show the effect of the drug on venous hemodynamics. The results showed that it has the following pharmacological characteristics. 2.1 Dose-effect relationship The parameters of venous volume plethysmography, including capacity, distensibility and emptying rate, have been measured. The dose-effect relationship with statistical significance has been determined. Taking 2 tablets can obtain the best dose-effect ratio. 2.2 Venous Tonicity Effect Diosmin can enhance venous tone: the change in parameters of venous occlusion volume plethysmography measured by mercury tensiometer shows that its emptying rate is reduced. 2.3 Microcirculatory effect A double-blind controlled study was conducted on patients with capillary fragility, and the changes in their fragility were measured using the vascular tension measurement method. The results showed that the difference between diosmin and placebo in improving capillary fragility was statistically significant.

Diosmin.

This product is a film-coated tablet, which appears yellow to brown after removing the coating.

Treatment of various symptoms related to venous lymphatic insufficiency (heaviness, pain in the legs, soreness and discomfort in the morning); treatment of various symptoms related to acute hemorrhoidal attacks.

1. Dosage: The usual dose is 0.5g (1 tablet), twice a day. When used for acute hemorrhoid attacks, take 1.5g twice a day for the first four days, and 1.0g twice a day for the next three days. 2. Dosage: Take this product orally at lunch and dinner.

There were a few reports of mild gastrointestinal reactions and autonomic nervous system disturbances, but none required discontinuation of treatment.

It is contraindicated for those who are allergic to any ingredient in this product.

Precautions for children: Detailed research data is still lacking. Precautions for pregnancy and lactation: 1. Use in pregnant women: Animal experiments have not shown any teratogenic effects. Furthermore, no harmful effects have been reported to humans so far. 2. Childbirth: Detailed research data is still lacking. 3. Use in lactating women: Although there is no data on the secretion of drugs in breast milk, breastfeeding is not recommended during treatment. Precautions for the elderly: Elderly patients aged 70 years and above, or those with other concurrent diseases (such as hypertension, atherosclerosis, diabetes, neurological/psychiatric diseases, and alcoholism), have no significant difference in the incidence of adverse reactions, and no obvious interaction between diosmin and drugs used to treat these diseases has been observed.

So far, no interactions with other drugs have been found.

Keep sealed.

0.5g(C28H32O150.45g)

24 months

Mayinglong Pharmaceutical Group Co., Ltd.

• Founded in:

  1994-05-09

• Address:

  No. 100, Zhoujiawan, Nanhu, Wuchang, Wuhan, Hubei

• Tax NO.:

  91420100177701670K

• Registered Funds:

  431.053891 yuan

• Website:

  Log in to view

• Email:

  Log in to view